ArticlePloS one2026

Real-life evaluation of BioFire® BCID2 and Vitek® REVEALTM for Gram-negative bloodstream infections in critical care.

Massinissa Benyahia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.